Vulcan Spinal System ↗
Multi-component posterior spinal fixation system for fusion procedures. [194][189]
FDA-clearedCommercially offered; exact model and country availability should be confirmed with the manufacturer.
Spinal implants, orthobiologics and enabling technologies built around an acquired spine-care portfolio.
VB Spine supplies implants, orthobiologics and enabling technologies for spinal surgery. The company was formed in April 2025 following the acquisition of Stryker’s U.S. spinal implants business by Viscogliosi Brothers.
Its portfolio includes the Vulcan spinal fixation system and acquired xvision spine-navigation rights. A February 2026 FDA decision for Vulcan names K2M, Inc. as applicant; the profile preserves that legal identity instead of rewriting the historical record under the VB Spine brand.
Anthony, John and Marc Viscogliosi serve as co-CEOs. Corporate headquarters are in Leesburg, Virginia, with a global manufacturing headquarters in Cestas, France. Portfolio integration, surgeon support and a global commercial organization underpin the company’s current operating model.
[178][179][180][181][182][183][184][185][186][187][188][190][192][194][195][196]
VB Spine’s selected portfolio includes Vulcan and the acquired xvision platform. The audit also records the inherited K2M spine-device history, retaining original applicants and pre-acquisition dates. Current corporate ownership and the exact scope of older models are separate questions; the snapshot remains a selection rather than a full acquired-product catalog. [192][196][195][130][129][180][182][1]
The matched FDA history contains 12 distinct recall events: 2 open, 10 terminated. 2 were initiated during the five years beginning October 20, 2021; older open events are also retained. Z-1307-2022 (2022-06-13; open, classified): Some of the rods in this lot were observed to have discoloration, later confirmed to be indication of trace amounts of inorganic phosphorous compound. This may produce a mild irritating or inflammatory response; adverse local tissue reactions may occur related to cytotoxicity… Z-0705-2022 (2022-01-13; open, classified): Stryker received two (2) complaints for units from specific lots of Inner and Outer Dilators not fitting together properly during a surgical procedure. Some dilators from these lots and from other lots were subsequently determined to be affected by a manufacturing nonconformance. [175][173][174]
Latest recorded source review: 2026-10-20.
Includes open events outside the mapped current portfolio; those events are excluded from the snapshot count.
Documented commercial product families.
Multi-component posterior spinal fixation system for fusion procedures. [194][189]
FDA-clearedCommercially offered; exact model and country availability should be confirmed with the manufacturer.
Acquired exclusive rights to the spine-navigation platform from Augmedics. [195]
Marketed · regulatory scope variesCommercially offered; exact model and country availability should be confirmed with the manufacturer.
VB Spine completed acquisition of exclusive rights to the xvision Spine System from Augmedics. [195]
Formation followed acquisition of the U.S. spinal implants business from Stryker. [196]
Accessed 10/29/2026